Effect of the dialysis membrane on mortality of chronic hemodialysis patients

Kidney International

Volumn 50, Issue 2, 1996, Pages 566-570

  Hakim, Raymond M ^a   Held, Philip J ^b   Stannard, David C ^b   Wolfe, Robert A ^b   Port, Friedrich K ^b   Daugirdas, John T ^b   Agodoa, Lawrence ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CELLULOSE;

ARTICLE; CLINICAL TRIAL; DEMOGRAPHY; DIALYSATE; DIALYSIS MEMBRANE; HEALTH SURVEY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK;

EID: 0029841840     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.350     Document Type: Article

References (21)

1. US RENAL DATA SYSTEM: USRDS Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 1995
2. PARKER TF, HUSNI L, HUANG W, LEW N, LOWRIE EG, DALLAS NEPHROLOGY ASSOCIATES: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23:670-680, 1994
3. HAKIM RM, BREYER JA, ISMAIL NM, SCHULMAN GM: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
4. COLLINS AJ, MA JZ, UMEN A, KESHAVIAH P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23:272-282, 1994
5. LEVIN NW, ZASUWA G, DUMLER F: effect of membrane types on causes of death in hemodialysis patients. (abstract) J Am Soc Nephrol 2:335, 1991
6. HORNBERGER JC, CHERNEW M, PETERSEN J, GARBER AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 3:1227-1237, 1993
7. LOWRIE EG, LEW NL, LIU Y: Evaluation of facility attributes associated with the standardized mortality ration (SMR). Internal Memorandum, NMC, March 30, 1993
8. DAUGIRDAS JT, DEPNER TA: A nomogram approach to hemodialysis urea modeling. Am J Kidney Dis 23:33-40, 1994
9. Statistical Analysis System (SAS) (Version 6). Cary, N.C., SAS Institute Inc., 1990
10. HELD PJ, WOLFE RA, GAYLIN DS, PORT FK, LEVIN NW, TURENNE MN: Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23:692-708, 1994
11. TEEHAN B, HAKIM RM: Continuous ambulatory peritoneal dialysis - Quo Vadis? J Am Soc Nephrol 6:139-142, 1995
12. SPIEGEL DM, BAKER PL, BABCOCK S, CONTIGUGLIA R, KLEIN M: Hemodialysis urea rebound: The effect of increasing dialysis efficiency. Am J Kidney Dis 25:26-29, 1995
13. HAKIM RM, WINGARD RL, VANHOLDER R, HUSNI L, PARKER TF: Effects of biocompatibility on hospitalizations and infectious morbidity in chronic hemodialysis patients. (abstract) J Am Soc Nephrol 5:450, 1994
14. PARKER TF, WINGARD RL, HUSNI L, IKIZLER TA, PARKER RA, HAKIM RM: The effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 49:551-556, 1996
15. VANHOLDER R, RINGOIR S, DHONDT A, HAKIM R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study. Kidney Int 39:320-327, 1991
16. 4 by hemodialyzer membranes: A novel index of biocompatibility. Klin Wochenschr 69:808-812, 1991
17. LUGER A, KOVARIK J, STUMMVOLL HK, URHANSKA A, LUGER TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
18. HAKIM RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
19. HOENICH NA, STENTON SC, WOFFINDIN C, LEVETT D, FAWCETT S, QUERESHI M, TAPSON JS, WARD MK: Comparison of membranes used in the treatment of end-stage renal failure. Kidney Int 33(Suppl 24):S44-S48, 1988
20. VANHOLDER R, DE SMET R, HSU C, VOGELEERE P, RINGOIR S: Uremic toxicity: The middle molecule hypothesis revisited. Semin Nephrol 13:205-218, 1994
21. DEPPISCH R, RITZ E, HANSCH GM, SCHOLS M, RAUTERBERG E-W: Bioincompatibility-Perspectives in 1993. Kidney Int 45(Suppl 44):S77-S84, 1994